What is Tyrosin Kinase inhibitor?

Tyrosinkinase inhibitor is a strong drug used to treat some types of cancer that do not respond well to other treatment options. The drug works by blocking the activity of specific enzymes that cancer cells must divide and replicate. There are dozens of different types of tyrosinekinase inhibitors and doctors choose the most suitable drugs that can be used on the basis of specific conditions of their patients, overall health and allergies. In most cases, the use of tyrosinekinase inhibitor is effective in slowing or stopping the growth of malignant tumors in the body.

Tyrosinkinase enzymes are vital components of most types of cells in the body. Combined with other enzymes and proteins, tyrosine kinases transmit signals that trigger a cell to divide their DNA and replicate. In a healthy cell, the enzyme is only active when replication is needed. Tyrosine kinases in cancer cells are always active. The result is a constant uncontrolled cell replica eventually leads to a tumor formation.

Replication of cancer cells can be controlled using a tyrosinek inhibitor. The drug connects to the enzyme and prevents it from signaling the beginning of the cell division process. As a result, the cells stop proliferating wildly and existing malignant cells will start to expire. Inhibitor drugs are sometimes able to fully erad the cancer from the body or at least increase the condition in patients with a late stage.

The doctor may decide to try Tyrosin Kinase inhibitor to combat cancer that cannot be surgically removed. Common non -functional conditions include blood and bone marrow cancer such as leukemia and multiple myeloma. The drug inhibitor can also be useful for solid tumors that would be too risky to work on them, such as masses that form in the brain or other vital organs. Because there are main risks of non -nighibitors and side effects are generally reserved PRO patients who are generally reserved in standard chemotherapy or radiation treatment.

Patients taking Tyrosin Kinase inhibitors can have a number of side effects. Common problems include headaches, weakness, nausea and diarrhea. The person may also have symptoms similar to flu and muscle, fever and chills. In some cases, more serious complications such as shortness of breath, heart palpitations, allergic reactions and anemia may occur.

Inhibitor drugs are often very effective in destroying cancer cells. However, they are not only able to target malignancy and healthy cells may suffer when tyrosinekinase inhibitor is used. The most important problem with the drug is the risk of damage to healthy white blood cells, vital components of the immune system. During therapy, patients are extremely immunocompromised and must take measures against exposure to anviral bacteria. By participating in regular checks and compliance with the doctor's recommendation, it is usually possible to avoid serious complicationsAnd reap only positive results from therapy.

IN OTHER LANGUAGES

Was this article helpful? Thanks for the feedback Thanks for the feedback

How can we help? How can we help?